Biorce raises €5M to accelerate drug development with AI. The investment from Norrsken VC will help enhance clinical trial efficiency and patient access to treatments.

Jul 08, 2025•13 days ago

Amount Raised

€5 Million

BarcelonaPharmaceuticalMedicalArtificial IntelligenceBiotechnologyHealth Care

Investors

Norrsken Vc

Description

Barcelona-based healthtech startup Biorce received €5 million in investment from Norrsken VC, Europe’s largest impact VC. The funding aims to address the operational inefficiencies in clinical trials using AI technology. Biorce’s platform simplifies the trial process, from patient recruitment to protocol design. CEO Pedro Coelho emphasized the need for faster and more accessible clinical trials.

Company Information

Company

Biorce

Location

Barcelona, Catalonia, Spain

About

Biorce is a Barcelona-based healthtech startup that leverages AI to address inefficiencies in clinical trials. Its platform, Jarvis, streamlines processes such as patient recruitment and trial protocol design, aiming to reduce delays and improve outcomes for patients. The company focuses on accelerating drug development and making clinical trials faster and more accessible. Biorce's technology is being adopted by leading pharmaceutical companies, biotechs, and CROs across various therapeutic areas.

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Biorce raises €5M to accelerate drug development with AI. The investment from Norrsken VC will help enhance clinical trial efficiency and patient access to treatments.

Investors

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information